fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Long COVID has a significant impact on UK workforce, study finds

Written by | 18 Jul 2022

Researchers have warned the long-term effects of coronavirus will have a significant impact on the UK workforce for some time. Of those who have been infected with Covid-19,… read more.

Simple skin biopsy can assess tissue damage related to COVID-19

Written by | 17 Jul 2022

Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal. This was not… read more.

Vaccine use in pregnancy: Deferring risk

Written by | 15 Jul 2022

Existing gaps and serious limitations concerning the information in vaccine product labels makes it challenging for healthcare providers to know when to recommend vaccination to pregnant women. A… read more.

Most British COVID-19 mourners suffer PTSD symptoms, survey finds

Written by | 10 Jul 2022

More than eight out of 10 British people who are seeking support for having lost a loved one to COVID-19 reported alarming Post Traumatic Stress Disorder symptoms, new… read more.

Half of long COVID patients show symptoms at 2 years

Written by | 8 Jul 2022

Researchers report that two years after diagnosis half of patients hospitalized with COVID-19 have at least one ongoing symptom. The findings appeared in on May 11, 2022 in… read more.

Sampling surfaces for COVID-19 virus at public health laboratories

Written by | 1 Jul 2022

Surface sampling for SARS-CoV-2 RNA has shown promise to detect the exposure of environments to infected individuals shedding the virus who would not otherwise be detected. Now a… read more.

NMPA (China) approves Paxlovid conditionally to treat COVID-19 – Pfizer

Written by | 30 Jun 2022

China’s medical products regulator has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the… read more.

Hormone replacement appears to reduce mortality in COVID-19

Written by | 23 Jun 2022

Researchers report that hormone replacement therapy is associated with a reduction in COVID-19 mortality. Their findings appeared on May 22, 2022 in Family Practice. “This study supports the… read more.

Text messaging shows promise in reaching unvaccinated patients

Written by | 16 Jun 2022

Automated text messaging was as effective as direct phone calls in getting unvaccinated patients to seek out a COVID-19 shot, according to a new study from the Perelman… read more.

Global study finds healthy eating got pricier in the pandemic

Written by | 15 Jun 2022

By now, most Americans have felt the effects of global crises on their grocery bills. Recent research published in the journal Nature Food has found this to be a worldwide… read more.

Most comprehensive analysis of COVID-19 data reveals previously unattributed deaths

Written by | 12 Jun 2022

In this first-of-its-kind study, researchers from University College London (UCL) combined multiple NHS datasets on national laboratory testing data, primary care consultations, hospitalisations and deaths to reveal the… read more.

Study finds COVID-19 pandemic reduced breast, cervical, colorectal cancer screenings by millions

Written by | 10 Jun 2022

New findings led by researchers at the American Cancer Society (ACS) show the number of women in the United States who reported having a recent (in the past year) breast cancer… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.